HUP0402241A2 - Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére - Google Patents
Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezeléséreInfo
- Publication number
- HUP0402241A2 HUP0402241A2 HU0402241A HUP0402241A HUP0402241A2 HU P0402241 A2 HUP0402241 A2 HU P0402241A2 HU 0402241 A HU0402241 A HU 0402241A HU P0402241 A HUP0402241 A HU P0402241A HU P0402241 A2 HUP0402241 A2 HU P0402241A2
- Authority
- HU
- Hungary
- Prior art keywords
- metformin
- oxobutanoic acid
- pharmaceutical composition
- combination
- carbon atoms
- Prior art date
Links
- UIUJIQZEACWQSV-UHFFFAOYSA-N succinic semialdehyde Chemical compound OC(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-N 0.000 title abstract 6
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003105 metformin Drugs 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya metformin és az (I) általános képletű 4-oxo-butánsav kombinációjából álló gyógyszerkészítmény, és ennekalkalmazása diabétesz kezelésére. A jelen találmány szerintigyógyszerkészítmény hatóanyagként metformint, adott esetbengyógyászatilag elfogadható sója formájában, és egy 4-oxobutánsavattartalmaz egy vagy több gyógyászatilag elfogadható hordozóvalösszekeverve. Ezek a készítmények különösen alkalmasak neminzulinfüggő diabétesz kezelésére. Az (I) általános képletben A és Bjelentése egymástól függetlenül -mono-, bi- vagy triciklusos 6-14szénatomos arilcsoport, -heteroaromás csoport, - 1-14 szénatomos alkilcsoport; - 5-8szénatomos cikloalkilcsoport; - telített heterociklusos csoport; afenti csoportok előnyösen 1-3-szor szubsztituáltak. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115398A FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
| PCT/EP2002/012355 WO2003045368A1 (en) | 2001-11-28 | 2002-11-06 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0402241A2 true HUP0402241A2 (hu) | 2005-02-28 |
Family
ID=8869889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0402241A HUP0402241A2 (hu) | 2001-11-28 | 2002-11-06 | Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050020609A1 (hu) |
| EP (1) | EP1448181B1 (hu) |
| JP (1) | JP2005515984A (hu) |
| KR (1) | KR20040058266A (hu) |
| CN (1) | CN1592615A (hu) |
| AT (1) | ATE327746T1 (hu) |
| AU (1) | AU2002351848A1 (hu) |
| BR (1) | BR0214487A (hu) |
| CA (1) | CA2468280A1 (hu) |
| CY (1) | CY1105165T1 (hu) |
| DE (1) | DE60211938T2 (hu) |
| DK (1) | DK1448181T3 (hu) |
| ES (1) | ES2266605T3 (hu) |
| FR (1) | FR2832633B1 (hu) |
| HU (1) | HUP0402241A2 (hu) |
| MX (1) | MXPA04005033A (hu) |
| PL (1) | PL369894A1 (hu) |
| PT (1) | PT1448181E (hu) |
| RU (1) | RU2004119817A (hu) |
| TW (1) | TW200300341A (hu) |
| WO (1) | WO2003045368A1 (hu) |
| ZA (1) | ZA200405021B (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1752147A4 (en) * | 2004-06-04 | 2007-10-31 | Kowa Co | MEDICINE FOR THE PREVENTION OR TREATMENT OF DIABETES |
| EP1792580A1 (en) | 2005-09-27 | 2007-06-06 | Ziterion GmbH | Two-part dental implants made of biocompatible ceramics |
| EP1967157A1 (en) | 2007-03-05 | 2008-09-10 | Ziterion GmbH | Hybrid two-part dental implant |
| EP2106767A1 (en) | 2008-03-31 | 2009-10-07 | Ziterion GmbH | Two-part dental implant |
| GB201004058D0 (en) * | 2010-03-11 | 2010-04-28 | Consiglio Nazionale Ricerche | Diagnostic assay for obesity and related disorders |
| WO2020064857A1 (en) * | 2018-09-28 | 2020-04-02 | Société des Produits Nestlé S.A. | Compounds that enhance the action of metformin |
| CN114349665B (zh) * | 2021-11-30 | 2023-06-09 | 潍坊博创国际生物医药研究院 | 二甲双胍焦谷氨酸晶体及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5863915A (en) * | 1996-05-15 | 1999-01-26 | Bayer Corporation | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease |
| FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| GB9922710D0 (en) * | 1999-09-24 | 1999-11-24 | Bayer Ag | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis |
| US6296874B1 (en) * | 2000-05-01 | 2001-10-02 | Aeropharm Technology Incorporated | Core formulation comprising troglitazone and abiguanide |
-
2001
- 2001-11-28 FR FR0115398A patent/FR2832633B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-06 KR KR10-2004-7006791A patent/KR20040058266A/ko not_active Application Discontinuation
- 2002-11-06 CN CNA028228375A patent/CN1592615A/zh active Pending
- 2002-11-06 CA CA002468280A patent/CA2468280A1/en not_active Abandoned
- 2002-11-06 PL PL02369894A patent/PL369894A1/xx not_active Application Discontinuation
- 2002-11-06 ES ES02787576T patent/ES2266605T3/es not_active Expired - Lifetime
- 2002-11-06 BR BR0214487-5A patent/BR0214487A/pt not_active IP Right Cessation
- 2002-11-06 US US10/497,145 patent/US20050020609A1/en not_active Abandoned
- 2002-11-06 JP JP2003546870A patent/JP2005515984A/ja active Pending
- 2002-11-06 AU AU2002351848A patent/AU2002351848A1/en not_active Abandoned
- 2002-11-06 EP EP02787576A patent/EP1448181B1/en not_active Expired - Lifetime
- 2002-11-06 WO PCT/EP2002/012355 patent/WO2003045368A1/en active IP Right Grant
- 2002-11-06 AT AT02787576T patent/ATE327746T1/de not_active IP Right Cessation
- 2002-11-06 PT PT02787576T patent/PT1448181E/pt unknown
- 2002-11-06 DK DK02787576T patent/DK1448181T3/da active
- 2002-11-06 MX MXPA04005033A patent/MXPA04005033A/es not_active Application Discontinuation
- 2002-11-06 RU RU2004119817/15A patent/RU2004119817A/ru not_active Application Discontinuation
- 2002-11-06 DE DE60211938T patent/DE60211938T2/de not_active Expired - Fee Related
- 2002-11-06 HU HU0402241A patent/HUP0402241A2/hu unknown
- 2002-11-22 TW TW091134094A patent/TW200300341A/zh unknown
-
2004
- 2004-06-24 ZA ZA200405021A patent/ZA200405021B/en unknown
-
2006
- 2006-08-23 CY CY20061101178T patent/CY1105165T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200405021B (en) | 2005-05-30 |
| US20050020609A1 (en) | 2005-01-27 |
| FR2832633B1 (fr) | 2004-09-24 |
| TW200300341A (en) | 2003-06-01 |
| DE60211938D1 (de) | 2006-07-06 |
| PL369894A1 (en) | 2005-05-02 |
| MXPA04005033A (es) | 2004-08-11 |
| EP1448181A1 (en) | 2004-08-25 |
| PT1448181E (pt) | 2006-10-31 |
| BR0214487A (pt) | 2004-10-19 |
| DE60211938T2 (de) | 2007-05-24 |
| ATE327746T1 (de) | 2006-06-15 |
| FR2832633A1 (fr) | 2003-05-30 |
| KR20040058266A (ko) | 2004-07-03 |
| CA2468280A1 (en) | 2003-06-05 |
| AU2002351848A1 (en) | 2003-06-10 |
| CY1105165T1 (el) | 2010-03-03 |
| EP1448181B1 (en) | 2006-05-31 |
| JP2005515984A (ja) | 2005-06-02 |
| ES2266605T3 (es) | 2007-03-01 |
| CN1592615A (zh) | 2005-03-09 |
| WO2003045368A1 (en) | 2003-06-05 |
| DK1448181T3 (da) | 2006-09-04 |
| RU2004119817A (ru) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001652A2 (hu) | Oxadiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0003386A2 (hu) | CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| HK1065483A1 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| HUP0102521A2 (hu) | Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer | |
| DOP2000000114A (es) | Oxazolidinonas substituidas y su uso | |
| HUP0401192A2 (hu) | Fényérzékenyítő szer alkalmazása sebek kezelésére adható gyógyászati készítmény előállítására | |
| AU9671798A (en) | Allosteric adenosine receptor modulators | |
| HUP0000057A2 (hu) | Fotokemoterápiás készítmények | |
| ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
| HUP0400368A2 (hu) | Oxitocin agonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk szexuális zavarok kezelésére | |
| HUP0400553A2 (hu) | Gyógyászati készítmények | |
| MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
| DE50012571D1 (de) | Biotin enthaltende galenische formulierung | |
| MY114944A (en) | Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use | |
| DK165903C (da) | Farmaceutisk praeparat mod acne | |
| MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
| HUP0402241A2 (hu) | Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére | |
| ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
| BR9708297A (pt) | Compostos composição farmacéutica cosmposição e uso de uma composição cosmética | |
| TR200103550T2 (tr) | Faktör VIIa inhibitörler. | |
| ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |